Risk of skin cancer among patients with chronic kidney disease treated with ultraviolet b phototherapy for uraemic pruritus: A nationwide cohort study

Mei Ju Ko; Jenq Wen Huang; Hon Yen Wu; Wan Chuan Tsai; Le Yin Hsu; Ping Hsiu Tsai; Kuo Liong Chien; Kuan Yu Hung

doi:10.2340/00015555-3758

Risk of skin cancer among patients with chronic kidney disease treated with ultraviolet b phototherapy for uraemic pruritus: A nationwide cohort study

Mei Ju Ko, Jenq Wen Huang, Hon Yen Wu, Wan Chuan Tsai, Le Yin Hsu, Ping Hsiu Tsai, Kuo Liong Chien, Kuan Yu Hung

Research output: Contribution to journal › Article › peer-review

9 Citations (Scopus)

Abstract

The safety of ultraviolet B (UVB) phototherapy with respect to cutaneous carcinogenesis has not been established for patients with chronic kidney disease. To investigate this issue, a nationwide cohort study of 10,805 patients with advanced chronic kidney disease was conducted using data from the National Health Insurance of Taiwan, the Taiwan Cancer Registry, and the national death registry. After a median follow-up of 75 months, 16 of 2,161 patients in the UVB group and 63 of 8,644 patients in the non-UVB group developed skin cancers. Compared with the non-UVB group, patients in the UVB group did not show an increased risk of skin cancer (hazard ratio 1.066; 95% confidence interval 0.584–1.944), non-melanoma skin cancer (hazard ratio 1.067; 95% confidence interval 0.571–1.996), or cutaneous melanoma (hazard ratio 1.009; 95% confidence interval 0.115–8.879). In addition, patients who received more UVB phototherapy did not show an increased risk of skin cancer. UVB phototherapy appears to be a safe treatment for uraemic pruritus in patients with chronic kidney disease.

Original language	English
Article number	adv00390
Pages (from-to)	1-6
Number of pages	6
Journal	Acta Dermato-Venereologica
Volume	101
Issue number	2
DOIs	https://doi.org/10.2340/00015555-3758
Publication status	Published - 2021
Externally published	Yes

Keywords

Chronic kidney disease
Skin cancer
Uraemic pruritus
UVB phototherapy

ASJC Scopus subject areas

Dermatology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2340/00015555-3758

Cite this

@article{d9d5990200ad44cb890a4ac9769726b6,

title = "Risk of skin cancer among patients with chronic kidney disease treated with ultraviolet b phototherapy for uraemic pruritus: A nationwide cohort study",

abstract = "The safety of ultraviolet B (UVB) phototherapy with respect to cutaneous carcinogenesis has not been established for patients with chronic kidney disease. To investigate this issue, a nationwide cohort study of 10,805 patients with advanced chronic kidney disease was conducted using data from the National Health Insurance of Taiwan, the Taiwan Cancer Registry, and the national death registry. After a median follow-up of 75 months, 16 of 2,161 patients in the UVB group and 63 of 8,644 patients in the non-UVB group developed skin cancers. Compared with the non-UVB group, patients in the UVB group did not show an increased risk of skin cancer (hazard ratio 1.066; 95% confidence interval 0.584–1.944), non-melanoma skin cancer (hazard ratio 1.067; 95% confidence interval 0.571–1.996), or cutaneous melanoma (hazard ratio 1.009; 95% confidence interval 0.115–8.879). In addition, patients who received more UVB phototherapy did not show an increased risk of skin cancer. UVB phototherapy appears to be a safe treatment for uraemic pruritus in patients with chronic kidney disease.",

keywords = "Chronic kidney disease, Skin cancer, Uraemic pruritus, UVB phototherapy",

author = "Ko, {Mei Ju} and Huang, {Jenq Wen} and Wu, {Hon Yen} and Tsai, {Wan Chuan} and Hsu, {Le Yin} and Tsai, {Ping Hsiu} and Chien, {Kuo Liong} and Hung, {Kuan Yu}",

note = "Funding Information: This study was supported by research grants to Dr HonYen Wu from the National Health Research Institutes, Taiwan (NHRIEX10810510PC, NHRIEX11011026PI) and the Far Eastern Memorial Hospital, New Taipei City, Taiwan (FEMHEX108-10510PC, FEMH2020C025), as well as by research grants to Dr MeiJu Ko from the Department of Health, Taipei City Government (1070162005, 1080162007) and the Taipei City Hospital, Taipei City, Taiwan (TPCH10917, TPCH10821). The funders had no role in study design, data collection, data analysis, manuscript preparation or publication decisions. Publisher Copyright: {\textcopyright} 2021, Medical Journals/Acta D-V. All rights reserved.",

year = "2021",

doi = "10.2340/00015555-3758",

language = "English",

volume = "101",

pages = "1--6",

journal = "Acta Dermato-Venereologica",

issn = "0001-5555",

publisher = "Medical Journals Sweden AB",

number = "2",

}

TY - JOUR

T1 - Risk of skin cancer among patients with chronic kidney disease treated with ultraviolet b phototherapy for uraemic pruritus

T2 - A nationwide cohort study

AU - Ko, Mei Ju

AU - Huang, Jenq Wen

AU - Wu, Hon Yen

AU - Tsai, Wan Chuan

AU - Hsu, Le Yin

AU - Tsai, Ping Hsiu

AU - Chien, Kuo Liong

AU - Hung, Kuan Yu

N1 - Funding Information: This study was supported by research grants to Dr HonYen Wu from the National Health Research Institutes, Taiwan (NHRIEX10810510PC, NHRIEX11011026PI) and the Far Eastern Memorial Hospital, New Taipei City, Taiwan (FEMHEX108-10510PC, FEMH2020C025), as well as by research grants to Dr MeiJu Ko from the Department of Health, Taipei City Government (1070162005, 1080162007) and the Taipei City Hospital, Taipei City, Taiwan (TPCH10917, TPCH10821). The funders had no role in study design, data collection, data analysis, manuscript preparation or publication decisions. Publisher Copyright: © 2021, Medical Journals/Acta D-V. All rights reserved.

PY - 2021

Y1 - 2021

N2 - The safety of ultraviolet B (UVB) phototherapy with respect to cutaneous carcinogenesis has not been established for patients with chronic kidney disease. To investigate this issue, a nationwide cohort study of 10,805 patients with advanced chronic kidney disease was conducted using data from the National Health Insurance of Taiwan, the Taiwan Cancer Registry, and the national death registry. After a median follow-up of 75 months, 16 of 2,161 patients in the UVB group and 63 of 8,644 patients in the non-UVB group developed skin cancers. Compared with the non-UVB group, patients in the UVB group did not show an increased risk of skin cancer (hazard ratio 1.066; 95% confidence interval 0.584–1.944), non-melanoma skin cancer (hazard ratio 1.067; 95% confidence interval 0.571–1.996), or cutaneous melanoma (hazard ratio 1.009; 95% confidence interval 0.115–8.879). In addition, patients who received more UVB phototherapy did not show an increased risk of skin cancer. UVB phototherapy appears to be a safe treatment for uraemic pruritus in patients with chronic kidney disease.

AB - The safety of ultraviolet B (UVB) phototherapy with respect to cutaneous carcinogenesis has not been established for patients with chronic kidney disease. To investigate this issue, a nationwide cohort study of 10,805 patients with advanced chronic kidney disease was conducted using data from the National Health Insurance of Taiwan, the Taiwan Cancer Registry, and the national death registry. After a median follow-up of 75 months, 16 of 2,161 patients in the UVB group and 63 of 8,644 patients in the non-UVB group developed skin cancers. Compared with the non-UVB group, patients in the UVB group did not show an increased risk of skin cancer (hazard ratio 1.066; 95% confidence interval 0.584–1.944), non-melanoma skin cancer (hazard ratio 1.067; 95% confidence interval 0.571–1.996), or cutaneous melanoma (hazard ratio 1.009; 95% confidence interval 0.115–8.879). In addition, patients who received more UVB phototherapy did not show an increased risk of skin cancer. UVB phototherapy appears to be a safe treatment for uraemic pruritus in patients with chronic kidney disease.

KW - Chronic kidney disease

KW - Skin cancer

KW - Uraemic pruritus

KW - UVB phototherapy

UR - http://www.scopus.com/inward/record.url?scp=85101259343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85101259343&partnerID=8YFLogxK

U2 - 10.2340/00015555-3758

DO - 10.2340/00015555-3758

M3 - Article

C2 - 33521834

AN - SCOPUS:85101259343

SN - 0001-5555

VL - 101

SP - 1

EP - 6

JO - Acta Dermato-Venereologica

JF - Acta Dermato-Venereologica

IS - 2

M1 - adv00390

ER -

Risk of skin cancer among patients with chronic kidney disease treated with ultraviolet b phototherapy for uraemic pruritus: A nationwide cohort study

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this